ELOXX PHARMACEUTICALS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Percent
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Percent of 0.00% for the 12-month period ending 2015-06-30, per its 10-K filed 2015-10-09.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization · last filed 2015-10-09
- ELOXX PHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, amortization, percent for fiscal 2015 was 0.00%.
- ELOXX PHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, amortization, percent for fiscal 2014 was 0.00%, a 100.00% decline from fiscal 2013.
- ELOXX PHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, amortization, percent for fiscal 2013 was 1.00%.
- ELOXX PHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, amortization, percent for fiscal 2012 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Percent 12 month |
|---|---|
| 2015-06-30 | 0.00% 10-K · filed 2015-10-09 |
| 2014-06-30 | 0.00% 10-K · filed 2015-10-09 |
| 2013-06-30 | 1.00% 10-K · filed 2015-10-09 |
| 2012-06-30 | 0.00% 10-K · filed 2014-09-29 |
| 2011-06-30 | 0.00% 10-K · filed 2013-09-11 |
| 2010-06-30 | -23.00% 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |